Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Takeda Pharmaceutical Buys Back Shares for $441 Million

12/02/2021 | 04:40am EST


ę MT Newswires 2021
All news about TAKEDA PHARMACEUTICAL COMPANY LIMITED
01/24Takeda to Hold Third Quarter FY2021 Earnings Conference Call
AQ
01/21TAKEDA PHARMACEUTICAL : to Hold Third Quarter FY2021 Earnings Conference Call
PU
01/19Takeda Named Global Top Employer for Fifth Consecutive Year
BU
01/13Denali Therapeutics Shares Fall as FDA Puts Alzheimer's Study Plan on Hold
DJ
01/13Takeda Pharmaceutical Buys Back $434 Million of Shares as Part of Buyback Program Set t..
MT
01/12Takeda Emphasizes Strategy for Delivering Sustainable Growth Over Next Decade at the 40..
AQ
01/12S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills
RE
01/11S.Korea authorizes Novavax COVID-19 vaccine, imports Pfizer pills
RE
01/11Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta T Cell Engager ..
AQ
01/11Takeda Pharmaceutical Says Its Global Brands Are Expected to Hit Revenue Growth Target
MT
More news
Analyst Recommendations on TAKEDA PHARMACEUTICAL COMPANY LIMITED
More recommendations
Financials
Sales 2022 3 410 B 29 733 M 29 733 M
Net income 2022 207 B 1 808 M 1 808 M
Net Debt 2022 3 307 B 28 830 M 28 830 M
P/E ratio 2022 24,5x
Yield 2022 5,44%
Capitalization 5 152 B 45 060 M 44 924 M
EV / Sales 2022 2,48x
EV / Sales 2023 2,37x
Nbr of Employees 47 099
Free-Float 98,2%
Chart TAKEDA PHARMACEUTICAL COMPANY LIMITED
Duration : Period :
Takeda Pharmaceutical Company Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TAKEDA PHARMACEUTICAL COMPANY LIMITED
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Last Close Price 3 308,00 JPY
Average target price 3 944,29 JPY
Spread / Average Target 19,2%
EPS Revisions
Managers and Directors
Christophe Weber Chief Operating & Corporate Officer
Constantine Saroukos Chief Financial Officer & Director
Andrew S. Plump Director, Research & Development President
Michael E. Mendelsohn Chief Medical & Scientific Officer
Norimasa Takeda Chief Accounting Officer & Corporate Controller
Sector and Competitors
1st jan.Capi. (M$)
TAKEDA PHARMACEUTICAL COMPANY LIMITED4.62%44 873
JOHNSON & JOHNSON-2.01%441 302
ROCHE HOLDING AG-8.68%304 745
PFIZER, INC.-11.02%294 900
ABBVIE INC.-1.71%235 287
ELI LILLY AND COMPANY-13.31%217 093